Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related C

@article{Takenaka2015CytomegalovirusRA,
  title={Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related C},
  author={Katsuto Takenaka and Tetsuya Nishida and Yuki Asano-Mori and Kumi Oshima and Kazuteru Ohashi and Takehiko Mori and Heiwa Kanamori and Koichi Miyamura and Chiaki Kato and Naoki Kobayashi and Naoyuki Uchida and Hirohisa Nakamae and Tatsuo Ichinohe and Yasuo Morishima and Ritsuro Suzuki and Takuhiro Yamaguchi and Takahiro Fukuda},
  journal={Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation},
  year={2015},
  volume={21 11},
  pages={
          2008-16
        }
}
Cytomegalovirus (CMV) infection is a major infectious complication after allogeneic hematopoietic cell transplantation (allo-HSCT). Recently, it was reported that CMV reactivation is associated with a decreased risk of relapse in patients with acute myeloid leukemia (AML). The aim of this study was to evaluate the impact of early CMV reactivation on the incidence of disease relapse after allo-HSCT in a large cohort of patients. The Japan Society for Hematopoietic Cell Transplantation's… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 26 CITATIONS

Similar Papers

Loading similar papers…